Show Only:   All Trust Scores   Reliable Users (3.0 Trust Score) Trusted Users (5.0 Trust Score) Elite Users (7.0 Trust Score)

Page:   123

Under Appreciated Adam Feuerstein

First off, let's give Adam a few claps, this man has busted more scams (HEB, CTIC come to mind) then Miami Vice.

Adam is a reporter for thestreet.com, so he does not trade, but he takes "the other side of the view" and looks at biotech with a skeptical eye, they way biotech should be viewed. He does his job by poking holes in companies stories instead of taking the companies stories for face value. Yes, Adam won't win many friends by doing this approach, because the companies shareholders who have already accepted the companies stories seem to get very upset by a different view.

When I read lines like "Adam is a basher", "Adam is working to get your shares cheap", that tells me Adam is doing some good work regarding the company, because I have read these lines over and over again on HEB or CTIC message boards.

Bottom Line: Adam F will ask and write the tough questions that either people don't want to know or would like ignorant bliss. I might add not always 100% correct on his opininos for certian biotechs, but a solid hit rate and no one that I know is perfect anyway. Great Job Adam...............! JW

Overall Rating
Education
Entertainment

3 of 4 people have found this review helpful.

Was this review helpful? Yes   No

22 March 2010
View Johnwelshphd's Profile

Excellent analysis

For years, Adam has done extremely thoughtful, unbiased analysis of biotech companies. He is not always correct, but he does work hard to focus on the facts. Many of the negative reviews of his work on this or other sites reflect an emotions-driven investment style typical of his largely individual investor reader base. As an institutional investor, I have found Adam's analysis to be thoughtful (and his writing concise, and often entertaining). Whether or not one agrees with his conclusion is beside the point. Most serious investors understand that fundamentals rule the day...the opinion of any one individual does not influence the eventual outcome. I would highly recommend Adam's work.

Overall Rating
Education
Entertainment

2 of 4 people have found this review helpful.

Was this review helpful? Yes   No

04 March 2010
View Buysider1's Profile

From thestreet.com

This guy is critical of all the pumps that matter. He speaks his mind and even after interviewing a CEO, he'll later speak his mind on their company and give his true reaction, and is usually hard-hitting. This is the guy you want to keep up with if you follow the bio sector. He's informed and does his research. I wouldn't long or short anything he's long/short, but there's definitely money to be made on the stocks he mentions. As always, play them with a strategy that works for you.

Thumbs up to this guy

Overall Rating
Education
Entertainment

1 of 3 people have found this review helpful.

Was this review helpful? Yes   No

28 February 2010
View Deadjim's Profile

No BS Approach

Adam covers the world of biotechs and it looks like he is the only non-corrupt guy in the world covering these carcasses. Busting scams like HEB and CTIC, he has opened the eyes of many gullible people who don't/can't understand the word of a biotech penny stock means less than that of a bum robing you at gunpoint...keep up the great work Adam and let us know when you spot another shady biotech...all are potential shorts as the odds of their success are horrific.

Overall Rating
Education
Entertainment

2 of 7 people have found this review helpful.

Was this review helpful? Yes   No

21 January 2010
View Tim's Profile

Knows his stuff

Adam is a smart guy, knows lots of the Biotechs. Asks hard hitting questions. I think he is fairly honest

Overall Rating
Education
Entertainment

2 of 3 people have found this review helpful.

Was this review helpful? Yes   No

27 April 2010
View Angelajk's Profile

Page:   123